Enovix Corporation Common Stock Earnings Recaps
Q1 2026
May 15, 2026
Enovix shares fell 13.6% as investors reacted negatively to cautious commentary on commercialization timelines and margin pressures despite progress in customer engagements and manufacturing. The market clearly signaled disappointment with the pace of scale and the lack of clear near-term revenue acceleration.
Key takeaways
- Q1 revenue was $7.6 million, driven by Korean military contractors, and grew 49% year-over-year but remains limited in scale.
- Non-GAAP gross margin contracted to 26.3%, highlighting ongoing margin pressures in early production stages.
- Commercial production commenced for the A1 battery in smart eyewear, with shipments ramping expected through H2, but smartphone qualification remains in early stages with updated testing protocols only recently aligned.
- Manufacturing yields improved, with most zones nearing or exceeding 90%, though Zone 1 dicing, a throughput bottleneck, is still being optimized with a hybrid dicing solution under development.
- The company emphasized active customer dialogues and a growing pipeline ($130 million) — primarily in drone and industrial markets — but scaled commercial launch timelines remain cautious with broader smartphone commercialization expected in 2027.
Q3 2025
Nov 6, 2025
Enovix Corporation delivered robust growth in Q3 2025, with revenue increasing 85% year-over-year to $8 million and achieving a significant gross profit margin while positioning itself strongly for future advancements in battery technology.
Key takeaways
- Revenue of $8 million marks an 85% increase year-over-year, driven by strong demand in defense and industrial sectors.
- Achieved a non-GAAP gross profit of $1.7 million, representing a 21% margin, a notable turnaround from the previous year.
- Successfully validated the AI-1 smartphone battery as the industry leader in energy density and fast charge capabilities, with key partnerships progressing toward commercialization.
- Total cash and marketable securities reached $648 million, empowering strategic initiatives, including funding for Fab2 and expanding manufacturing capabilities.
- Significant yield improvements and cost optimizations in production processes give Enovix a substantial competitive edge as it prepares for broader market launches in 2026.